Shala Dezfouli

Inflammatory Disease and Lymphomagenesis Caused by Deletion of the Myc Antagonist Mnt in T Cells

A. Wynshaw-Boris, P. Hurlin, Jie Huang, 2006, Molecular and Cellular Biology.

Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia–reperfusion injury

M. Hickey, K. Peter, S. Robson, 2017, Purinergic Signalling.

Functions of myc:max in the control of cell proliferation and tumorigenesis.

P. Hurlin, S. Dezfouli, Shala Dezfouli, 2004, International review of cytology.

Antiinflammatory and Anticoagulant Effects of Transgenic Expression of Human Thrombomodulin in Mice

E. Salvaris, S. Robson, C. Selan, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNγ primed and IFNβ treated B7‐1+ B16‐F10 melanoma cells

S. Ralph, I. Hatzinisiriou, S. Dezfouli, 2003, Immunology and cell biology.

Evidence of Platelet Activation at Medically Used Hypothermia and Mechanistic Data Indicating ADP as a Key Mediator and Therapeutic Target

M. Hickey, K. Peter, H. Wendel, 2011, Arteriosclerosis, thrombosis, and vascular biology.